• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Medisyn Technologies, Inc. - Product Pipeline Review - Q4 2010 Product Image

Medisyn Technologies, Inc. - Product Pipeline Review - Q4 2010

  • ID: 1446321
  • November 2010
  • 28 pages
  • GlobalData

Medisyn Technologies, Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Medisyn Technologies, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Medisyn Technologies, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Medisyn Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including READ MORE >



List of Tables
List of Figures
Medisyn Technologies, Inc. Snapshot
Medisyn Technologies, Inc. Overview
Key Information
Key Facts
Medisyn Technologies, Inc. – Research and Development Overview
Key Therapeutic Areas
Medisyn Technologies, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Medisyn Technologies, Inc. – Pipeline Products Glance
Medisyn Technologies, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Medisyn Technologies, Inc. – Drug Profiles
MT477
Product Description
Mechanism of Action
R&D Progress
Anti-Aggregation Agents
Product Description
Mechanism of Action
R&D Progress
MT062
Product Description
Mechanism of Action
R&D Progress
MT103
Product Description
Mechanism of Action
R&D Progress
Selective Aß1-40 And Aß1-42 Lowering Agents
Product Description
Mechanism of Action
R&D Progress
Medisyn Technologies, Inc. – Pipeline Analysis
Medisyn Technologies, Inc. – Pipeline Products by Therapeutic Class
Medisyn Technologies, Inc. Pipeline Products By Target
Medisyn Technologies, Inc. – Pipeline Products by Route of Administration
Medisyn Technologies, Inc. – Pipeline Products by Molecule Type
Medisyn Technologies, Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Mar 03, 2010: Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
Mar 03, 2010: Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
Sep 13, 2007: Mount Sinai School Of Medicine And Medisyn Technologies Announce Agreement To Discover Novel Therapeutics For Treating Alzheimer's Disease
Sep 13, 2007: Mount Sinai School Of Medicine And Medisyn Technologies Announce Agreement To Discover Novel Therapeutics For Treating Alzheimer's Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS